IMPACT OF DELAYED TREATMENT INITIATION WITH RESMETIROM IN PATIENTS WITH NONCIRRHOTIC NONALCOHOLIC STEATOHEPATITIS (NASH) WITH MODERATE TO ADVANCED FIBROSIS

被引：0
|
作者：
Ansaripour, A. [1 ]
Kim, Y. [2 ]
Montero, M. Gomez [1 ]
Hosmane, S. [2 ]
机构：
[1] Optimax Access, Rotterdam, ZH, Netherlands
[2] Madrigal Pharmaceut, Jersey City, NJ USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE511
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Exploring factors related to clinically advanced fibrosis in patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis
    Yu, Anthony
    Ritenour, Alexandra
    Vincent, Jennifer
    Park, Chanhyun
    Rascati, Karen
    Godley, Paul
    POSTGRADUATE MEDICINE, 2024, 136 (01) : 14 - 21
  • [42] Enhancing prediction of moderate fibrosis in MASLD patients for Resmetirom treatment via machine learning
    Dunn, Winston
    Alkhouri, Naim
    Yip, Terry Cheuk-Fung
    Castera, Laurent
    Takawy, Marina
    Adams, Leon
    Verma, Nipun
    Arab, Juan Pablo
    Jafri, Syed-Mohammed
    Zhong, Bihui
    Dubourg, Julie
    Chen, Vincent
    Singal, Ashwani K.
    Antonio Diaz, Luis
    Dunn, Nicholas
    Nadeem, Rida
    Wong, Vincent Wai-Sun
    Abdelmalek, Manal F.
    Wang, Zhengyi
    Duseja, Ajay Kumar
    Almahanna, Yousef
    Bajunayd, Amani
    Omeish, Haya A.
    Ye, Junzhao
    Harrison, Stephen A.
    Wong, Grace Lai-Hung
    Arrese, Marco
    Robert, Sage
    Shao, Congxiang
    JOURNAL OF HEPATOLOGY, 2024, 80 : S84 - S84
  • [43] VALIDATION OF HISTOLOGIC AND NONINVASIVE MEASURES OF FIBROSIS AS SURROGATE ENDPOINTS OF DISEASE PROGRESSION IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)
    Anstee, Quentin M.
    Trauner, Michael H.
    Lawitz, Eric J.
    Bzowej, Natalia
    Vuppalanchi, Raj
    Younes, Ziad
    Ding, Dora
    Li, Georgia
    Kersey, Kathryn
    Camargo, Marianne
    Djedjos, Stephen
    Subramanian, Mani
    Myers, Robert P.
    Wong, Vincent Wai-Sun
    Harrison, Stephen A.
    Okanoue, Takeshi
    Romero-Gomez, Manuel
    Goodman, Zackary
    HEPATOLOGY, 2019, 70 : 1342A - 1343A
  • [44] Rising Healthcare Costs and Comorbidities Among Nonalcoholic Steatohepatitis (NASH) Patients with Advanced Fibrosis and Cirrhosis: A Longitudinal Real-World Analysis of US Patients
    Loomba, Rohit
    Hulbert, Erin
    Shreay, Sanatan
    Harrison, Stephen A.
    HEPATOLOGY, 2017, 66 : 1131A - 1132A
  • [45] ENHANCING PREDICTION OF MODERATE FIBROSIS OR HIGHER IN MASLD PATIENTS FOR RESMETIROM TREATMENT VIA MACHINE LEARNING
    Dunn, Winston
    Alkhouri, Naim
    Yip, Terry Cheuk-Fung
    Castera, Laurent
    Takawy, Marina
    Adams, Leon
    Verma, Nipun
    Arab, Juan Pablo
    Jafri, Syed-Mohammed
    Zhong, Bihui
    Dubourg, Julie
    Chen, Vincent
    Singal, Ashwani
    Antonio Diaz, Luis
    Dunn, Nicholas
    Nadeem, Rida
    Wong, Vincent
    Abdelmalek, Manal
    Wang, Zhengyi
    Duseja, Ajay
    Almahanna, Yousef
    Omeish, Haya
    Ye, Junzhao
    Harrison, Stephen
    Arrese, Marco
    Robert, Sage
    Wong, Grace Lai-Hung
    Bajunayd, Bajunayd
    Shao, Congxiang
    HEPATOLOGY, 2024, 80 : S553 - S555
  • [46] Estimating the Impact of Hypothetical Treatment for Patients with Advanced Non-Alcoholic Steatohepatitis (NASH) on Clinical Outcomes
    Younossi, Zobair M.
    Tampi, Radhika
    Nader, Fatema
    Younossi, Issah
    Cable, Rebecca
    Srishord, Manirath
    Racila, Andrei
    HEPATOLOGY, 2018, 68 : 982A - 982A
  • [47] Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis
    Manka, Paul
    Bechmann, Lars
    Best, Jan
    Sydor, Svenja
    Claridge, Lee C.
    Coombes, Jason D.
    Canbay, Ali
    Moeller, Lars
    Gerken, Guido
    Wedemeyer, Heiner
    Syn, Wing-Kin
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (08) : 2351 - 2358
  • [48] INCREASED CARDIOVASCULAR AND KIDNEY DISEASE RISK IN PATIENTS WITH ADVANCED FIBROSIS DUE TO NONALCOHOLIC STEATOHEPATITIS
    Corey, Kathleen E.
    Xu, Jun
    Lim, Sharlene
    Zhu, Kaiyi
    Malkov, Vladislav A.
    Melehani, Jason
    Boyette, Lisa
    Watkins, Timothy R.
    Billin, Andrew N.
    HEPATOLOGY, 2023, 78 : S816 - S817
  • [49] Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis
    Paul Manka
    Lars Bechmann
    Jan Best
    Svenja Sydor
    Lee C. Claridge
    Jason D. Coombes
    Ali Canbay
    Lars Moeller
    Guido Gerken
    Heiner Wedemeyer
    Wing-Kin Syn
    Digestive Diseases and Sciences, 2019, 64 : 2351 - 2358
  • [50] THE CLINICAL IMPACT OF LEAN NASH ON POST-LIVER TRANSPLANT PROGNOSIS OF PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS
    Lee, David U.
    Han, John
    Chang, Kevin
    Kwon, Jean
    Fan, Gregory H.
    Jung, Daniel
    Urrunaga, Nathalie H.
    GASTROENTEROLOGY, 2022, 162 (07) : S1234 - S1235
12345